TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35276662

Group type: EXPERIMENTAL
Intervention: Training Group (TG) - variable practice training with weighted wrist bands, twice a week for 1 month
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control Group (CG) - same number of sessions and volume of training as TG
Number of subjects: 34
Study: 34548360

Group type: EXPERIMENTAL
Intervention: Clinical medical review with spirometry
Number of subjects: 106

Group type: COMPARATOR
Intervention: Clinical medical review without spirometry
Number of subjects: 106
Study: 36346079

Group type: EXPERIMENTAL
Intervention: Bepirovirsen 300 mg weekly for 24 weeks (group 1)
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Bepirovirsen 300 mg for 12 weeks then 150 mg for 12 weeks (group 2)
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Bepirovirsen 300 mg for 12 weeks then placebo for 12 weeks (group 3)
Number of subjects: 457

Group type: COMPARATOR
Intervention: Placebo for 12 weeks then Bepirovirsen 300 mg for 12 weeks (group 4)
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Bepirovirsen (groups 1, 2, and 3)
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Bepirovirsen 300 mg weekly for 24 weeks
Number of subjects: 457
Study: 35871853

Group type: COMPARATOR
Intervention: Tension Band Wiring (TBW)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: CIN with 1 conical locking screw (CIN-1)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: CIN with 3 conical locking screws (CIN-3)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: CIN-3
Number of subjects: 15
Study: 34323384

Group type: EXPERIMENTAL
Intervention: Modified catheterisation technique
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional catheterisation
Number of subjects: 60
Study: 32729802

Group type: EXPERIMENTAL
Intervention: Inoculated with 2×2 cm plug of 5-day-old mycelium of P. capsici
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Inoculated with 10 μL of zoospore suspension (2 × 105 zoospore/ml)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control treated with sterile distilled water
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control treated with agar plug
Number of subjects: 60
Study: 36153525

Group type: EXPERIMENTAL
Intervention: Pulmonary Rehabilitation (PR)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 95
Study: 33030064

Group type: EXPERIMENTAL
Intervention: Renal sympathetic denervation (RDN)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Drug adjustment
Number of subjects: 19
Study: 36314847

Group type: EXPERIMENTAL
Intervention: Peer-led online intervention (Harnessing Online Peer Education)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 33876439

Group type: EXPERIMENTAL
Intervention: Chronic use of RAAS blockers
Number of subjects: 1160

Group type: COMPARATOR
Intervention: Non-use of RAAS blockers
Number of subjects: 1160
Study: 34799501

Group type: EXPERIMENTAL
Intervention: Dexamethasone 3 mg
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Dexamethasone 6 mg
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Dexamethasone 12 mg
Number of subjects: 714

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 714
Study: 34145121

Group type: EXPERIMENTAL
Intervention: Paclitaxel-Coated Balloons (PCB)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Plain Balloon Angioplasty (PTA)
Number of subjects: 23
Study: 32610608

Group type: EXPERIMENTAL
Intervention: Leucine-Enriched Amino Acid Supplement with breakfast
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Leucine-Enriched Amino Acid Supplement post-exercise
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Exercise intervention (two sessions a day for two months)
Number of subjects: 46
Study: 33526855

Group type: EXPERIMENTAL
Intervention: Weight Loss (WL)
Number of subjects: 177
Study: 32548951

Group type: EXPERIMENTAL
Intervention: Exposure-short (EXP-S)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Exposure-long (EXP-L)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Exposure treatments (EXP)
Number of subjects: 67
Study: 36039506

Group type: EXPERIMENTAL
Intervention: Individual cognitive processing therapy (CPT)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Group cognitive processing therapy (CPT)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Individual CPT
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: CPT (both formats)
Number of subjects: 268
Study: 32175776

Group type: EXPERIMENTAL
Intervention: Intensive self-regulation training
Number of subjects: 0
Study: 32915921

Group type: EXPERIMENTAL
Intervention: Weight cycling (average number of cycles = 7.82)
Number of subjects: 2702

Group type: EXPERIMENTAL
Intervention: Internalized weight stigma
Number of subjects: 2702
Study: 34034897

Group type: EXPERIMENTAL
Intervention: Implant-retained removable dentures
Number of subjects: 129

Group type: COMPARATOR
Intervention: Frequency of tooth or denture cleaning (1 time a day)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Frequency of tooth or denture cleaning (2-3 times a day)
Number of subjects: 129
Study: 32492126

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Best medical treatment
Number of subjects: 100
Study: 34363999

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment (3 commonly prescribed antidepressants)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Baseline neuroticism
Number of subjects: 226
Study: 33632598

Group type: EXPERIMENTAL
Intervention: Single Carbohydrate Intake (SCI)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Distributed Carbohydrate Intake (DCI)
Number of subjects: 33
Study: 35179449

Group type: EXPERIMENTAL
Intervention: Programmed fluid intake (P-HYD)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No fluid intake (DEH)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ad libitum fluid intake (AL-HYD)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Incremental exercise test
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Biomechanical properties of the hand
Number of subjects: 10
Study: 33970517

Group type: EXPERIMENTAL
Intervention: PTR radiomics signatures
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Integrated models combining PTR radiomics signature with clinical characteristics
Number of subjects: 284

Group type: COMPARATOR
Intervention: ITR radiomics signatures
Number of subjects: 284

Group type: COMPARATOR
Intervention: Clinical characteristics
Number of subjects: 284
Study: 32988525

Group type: EXPERIMENTAL
Intervention: 0.02% ABP
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: 0.04% ABP
Number of subjects: 1200
Study: 34604936

Group type: EXPERIMENTAL
Intervention: Laser-microgrooved implants with laser-microgrooved prosthetic abutments
Number of subjects: 20

Group type: COMPARATOR
Intervention: Laser-microgrooved implants with machined prosthetic abutments
Number of subjects: 20
Study: 32408038

Group type: EXPERIMENTAL
Intervention: Combined eccentric-concentric rehabilitation (ECC-CON, n=10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Concentric rehabilitation (CN, n=10)
Number of subjects: 20
Study: 33975553

Group type: COMPARATOR
Intervention: GnRH antagonist protocol (fresh transfer cycles)
Number of subjects: 1119

Group type: EXPERIMENTAL
Intervention: Depot GnRH agonist protocol (fresh transfer cycles)
Number of subjects: 1119

Group type: COMPARATOR
Intervention: GnRH antagonist protocol (frozen-thawed transfer cycles)
Number of subjects: 1119

Group type: EXPERIMENTAL
Intervention: Depot GnRH agonist protocol (frozen-thawed transfer cycles)
Number of subjects: 1119
Study: 32108253

Group type: EXPERIMENTAL
Intervention: Patellar brace
Number of subjects: 50
Study: 34581769

Group type: EXPERIMENTAL
Intervention: Automated behavioral workplace intervention with traffic-light labeling system
Number of subjects: 397

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 397

Group type: COMPARATOR
Intervention: Baseline comparison between Q4 and Q1
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: 12-month follow-up comparison between Q4 and Q1
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: 24-month follow-up comparison between Q4 and Q1
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Overall conclusion
Number of subjects: 397
Study: 33929343

Group type: EXPERIMENTAL
Intervention: Culprit-only revascularization strategy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Time from medical contact to revascularization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transradial vascular access
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early initialization of mechanical circulatory support
Number of subjects: 0
Study: 34273604

Group type: EXPERIMENTAL
Intervention: Detoxification for one month
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Detoxification for three months
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Detoxification for six months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (20 healthy women)
Number of subjects: 60
Study: 32210475

Group type: EXPERIMENTAL
Intervention: Financial incentives
Number of subjects: 0
Study: 33302704

Group type: EXPERIMENTAL
Intervention: Interpersonal and social rhythm therapy (with or without cognitive remediation)
Number of subjects: 20
Study: 32047951

Group type: EXPERIMENTAL
Intervention: Romosozumab followed by alendronate
Number of subjects: 275

Group type: COMPARATOR
Intervention: Alendronate alone
Number of subjects: 275
Study: 35937566

Group type: EXPERIMENTAL
Intervention: Remimazolam besylate
Number of subjects: 75

Group type: COMPARATOR
Intervention: Dexmedetomidine
Number of subjects: 75
Study: 33065120

Group type: EXPERIMENTAL
Intervention: CSL112 6 g
Number of subjects: 17400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17400
Study: 32070309

Group type: EXPERIMENTAL
Intervention: Postoperative chemoradiotherapy (POCRT) with 50.4 Gy concurrent with paclitaxel (135-150 mg/m2) plus cisplatin or nedaplatin (50-75 mg/m2) every 28 days for two cycles.
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (PORT) with a prescription dose of 54 Gy.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Surgery alone (SA).
Number of subjects: 120
Study: 616737893

Group type: EXPERIMENTAL
Intervention: DIME expert‐supervised (DES) group
Number of subjects: 1313

Group type: COMPARATOR
Intervention: DIME cadre‐supervised (DCS) group
Number of subjects: 1313
Study: 36228406

Group type: EXPERIMENTAL
Intervention: Tai chi intervention (8 weeks)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (routine care only)
Number of subjects: 72
Study: 33571868

Group type: EXPERIMENTAL
Intervention: Ivacaftor (28 days)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Open-label extension (5 months)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Baseline to end of open-label extension
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (28 days)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Follow-up (2 years)
Number of subjects: 20
Study: 32522125

Group type: EXPERIMENTAL
Intervention: High protein and energy supplementation (Atole)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No protein and low energy supplementation (Fresco)
Number of subjects: 0
Study: 35324270

Group type: EXPERIMENTAL
Intervention: Biosimilar pegfilgrastim (PegFilBS)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Originator pegfilgrastim (PegFilOR)
Number of subjects: 120
Study: 35398370

Group type: EXPERIMENTAL
Intervention: Weight loss intervention (individual clinic visits)
Number of subjects: 1177

Group type: EXPERIMENTAL
Intervention: Weight loss intervention (other unspecified arms)
Number of subjects: 1177
Study: 35878838

Group type: EXPERIMENTAL
Intervention: Infliximab treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 40
Study: 35229777

Group type: EXPERIMENTAL
Intervention: Microabrasion + resin infiltration (fluorosis with stains)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Microabrasion + remineralization (fluorosis with stains)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Microabrasion + resin infiltration (fluorosis without stains)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Microabrasion + remineralization (fluorosis without stains)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Resin infiltration
Number of subjects: 120

Group type: COMPARATOR
Intervention: Remineralization
Number of subjects: 120
Study: 33849104

Group type: EXPERIMENTAL
Intervention: Psychological intervention during the perioperative period
Number of subjects: 92
Study: 33140981

Group type: EXPERIMENTAL
Intervention: reSET-O PDT
Number of subjects: 3144

Group type: EXPERIMENTAL
Intervention: reSET-O PDT (subgroup analysis)
Number of subjects: 3144
Study: 33153439

Group type: EXPERIMENTAL
Intervention: 20 Hz vibration therapy for 20 weeks, 9 min per day, 4 times a week
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 25 Hz vibration therapy for 20 weeks, 9 min per day, 4 times a week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (12-week lead-in period prior to intervention)
Number of subjects: 0
Study: 34706567

Group type: EXPERIMENTAL
Intervention: 2.5% NaOCl lavage
Number of subjects: 96

Group type: COMPARATOR
Intervention: Physiologic saline solution
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: MMP-9/TP levels
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: NaOCl lavage
Number of subjects: 96
Study: 34526100

Group type: EXPERIMENTAL
Intervention: NMES plus standard care
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sham-NMES plus standard care
Number of subjects: 58
Study: 32527349

Group type: EXPERIMENTAL
Intervention: Minimum air leakage method
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cuff pressure manometer method
Number of subjects: 100
Study: 35247334

Group type: EXPERIMENTAL
Intervention: Topical LHA510 (twice a day for 8 weeks, then 3 times a day for 4 weeks)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 90
Study: 33054121

Group type: EXPERIMENTAL
Intervention: Zanubrutinib 160 mg twice daily
Number of subjects: 109
Study: 35430026

Group type: EXPERIMENTAL
Intervention: Alloderm group (n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (n=30)
Number of subjects: 60
Study: 33181659

Group type: EXPERIMENTAL
Intervention: Hominis placenta pharmacopuncture
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline pharmacopuncture (Control)
Number of subjects: 30
Study: 34013542

Group type: EXPERIMENTAL
Intervention: Self-applied transcutaneous electrical nerve stimulation (TENS) device
Number of subjects: 74

Group type: COMPARATOR
Intervention: Sham group (active placebos)
Number of subjects: 74
Study: 32623673

Group type: COMPARATOR
Intervention: 100% DW
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 25% TGW + 75% DW
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 50% TGW + 50% DW
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 75% TGW + 25% DW
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 100% TGW
Number of subjects: 4
Study: 36180101

Group type: EXPERIMENTAL
Intervention: IFX‐qbtx (3 mg/kg intravenous at weeks 0, 2 and 6, then every 8 weeks)
Number of subjects: 1247

Group type: COMPARATOR
Intervention: IFX‐EU (3 mg/kg intravenous at weeks 0, 2 and 6, then every 8 weeks)
Number of subjects: 1247

Group type: EXPERIMENTAL
Intervention: ADL‐afzb (40 mg subcutaneous every other week)
Number of subjects: 1247

Group type: COMPARATOR
Intervention: ADL‐EU (40 mg subcutaneous every other week)
Number of subjects: 1247
Study: 34346266

Group type: EXPERIMENTAL
Intervention: IND/MF high-dose (150/320 μg)
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: IND/MF medium-dose (150/160 μg)
Number of subjects: 323

Group type: COMPARATOR
Intervention: SAL/FLU high-dose (50/500 μg)
Number of subjects: 323
Study: 33759964

Group type: EXPERIMENTAL
Intervention: Video-assisted training
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Hands-on training
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard printed educational material with verbal information (Control)
Number of subjects: 90
Study: 33755779

Group type: EXPERIMENTAL
Intervention: Regular treatment and medical consultations for residents with Parkinson's disease
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Nursing staff knowledge and training
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Frequency of falls and hospital stays
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Parkinson-specific assistive technologies
Number of subjects: 85
Study: 33491438

Group type: EXPERIMENTAL
Intervention: Fya antigen
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Fyb antigen
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: FY phenotypes
Number of subjects: 143
Study: 36125835

Group type: EXPERIMENTAL
Intervention: intermittent theta burst stimulation (iTBS)
Number of subjects: 28

Group type: COMPARATOR
Intervention: sham stimulation
Number of subjects: 28
Study: 35277011

Group type: EXPERIMENTAL
Intervention: RLX2™ containing alpha‐s1‐casein tryptic hydrolysate and L‐theanine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 33278754

Group type: EXPERIMENTAL
Intervention: Informed family member (IFM) present during awakening process in ICU
Number of subjects: 73

Group type: COMPARATOR
Intervention: Routine care and treatment practices without family presence
Number of subjects: 73
Study: 34780993

Group type: EXPERIMENTAL
Intervention: Virtual placebo (sham heat protective glove)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Physical placebo administered to the own, physical body
Number of subjects: 48
Study: 33631102

Group type: EXPERIMENTAL
Intervention: Microbial Ecosystem Therapeutic 2 (MET‐2); initial daily treatment of 10 oral capsules for 2 days, then 3 capsules for 8 days; higher dose if recurrence: 20 capsules for 2 days, then 3 capsules for 8 days.
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Microbial Ecosystem Therapeutic 2 (MET‐2)
Number of subjects: 19
Study: 34310715

Group type: COMPARATOR
Intervention: Coronally advanced flap (CAF)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Coronally advanced flap plus collagen matrix (CAF + CM)
Number of subjects: 62
Study: 33098276

Group type: EXPERIMENTAL
Intervention: 15 hrs per week of discrete trial teaching (DTT)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: 25 hrs per week of discrete trial teaching (DTT)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: 15 hrs per week of naturalistic developmental behavioral intervention (NDBI)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: 25 hrs per week of naturalistic developmental behavioral intervention (NDBI)
Number of subjects: 87
Study: 34102298

Group type: EXPERIMENTAL
Intervention: Topical steroid
Number of subjects: 211

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 211
Study: 35779302

Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine (2 μg/kg)
Number of subjects: 86
Study: 33819335

Group type: EXPERIMENTAL
Intervention: Convex abutment (Group CX)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Concave abutment (Group CV)
Number of subjects: 28
Study: 34131804

Group type: EXPERIMENTAL
Intervention: APTw imaging and radiomic features
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: APTw-derived radiomics algorithm
Number of subjects: 81

Group type: COMPARATOR
Intervention: APTw measures
Number of subjects: 81
Study: 36053504

Group type: EXPERIMENTAL
Intervention: FFR-guided procedure
Number of subjects: 1682

Group type: COMPARATOR
Intervention: IVUS-guided procedure
Number of subjects: 1682

Group type: EXPERIMENTAL
Intervention: FFR and IVUS guidance
Number of subjects: 1682
Study: 32147060

Group type: EXPERIMENTAL
Intervention: Fenugreek seed (FS) supplementation (5 g FS powder, 3 times a day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (anti-diabetic drugs and nutritional consults)
Number of subjects: 50
Study: 33347020

Group type: EXPERIMENTAL
Intervention: Aripiprazole (high and low doses)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 32113924

Group type: EXPERIMENTAL
Intervention: Ambulatory oxygen delivered via portable concentrators
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham control (air delivered via portable concentrators)
Number of subjects: 30
Study: 36477234

Group type: EXPERIMENTAL
Intervention: Manual self-pollination
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nocturnal open pollination
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Diurnal open pollination
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Manual cross-pollination (red-fleshed pitaya pollen on white-fleshed pitaya stigma)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Natural pollination
Number of subjects: 16
Study: 34836088

Group type: EXPERIMENTAL
Intervention: Single-dose intake of 1.3 g of polyphenol-rich cocoa powder
Number of subjects: 20

Group type: COMPARATOR
Intervention: Daily consumption of 1.3 g of polyphenol-rich cocoa powder for 28 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Single-dose intake and sustained supplementation
Number of subjects: 20
Study: 33125438

Group type: EXPERIMENTAL
Intervention: Movements of confederates who belonged to the same social category as participants
Number of subjects: 965
Study: 35085249

Group type: EXPERIMENTAL
Intervention: Buprenorphine (target concentrations of 0.5 ng/mL in healthy volunteers)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Buprenorphine (all concentration groups combined in opioid-tolerant patients)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 34217164

Group type: EXPERIMENTAL
Intervention: Short-term spinal cord electrical stimulation (stSCS)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Nerve block therapy (Control)
Number of subjects: 160
Study: 35562713

Group type: EXPERIMENTAL
Intervention: PEG‐rhG‐CSF
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study: 32116098

Group type: EXPERIMENTAL
Intervention: Botulinum toxin treatment
Number of subjects: 130
Study: 33218534

Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT) applied to facilitate erector spinae
Number of subjects: 16
Study: 35860186

Group type: EXPERIMENTAL
Intervention: Minimally invasive tarsal sinus approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lateral L-shaped incision approach (Control)
Number of subjects: 0